News | Mammography | October 16, 2015

Dutch Study Reaffirms Importance of Early Detection for Breast Cancer

Findings demonstrate size of tumor, involvement of lymph nodes directly impact overall long-term survival

breast cancer, early detection, BMJ, Dutch study, Elaine Schattner, lymph nodes, tumor size

October 14, 2015 — Findings from a new population-based study in the Netherlands appear to reaffirm that early detection of breast cancer positively impacts long-term patient survival.

The study — based out of Erasmus University Medical Centre, the Netherlands Comprehensive Cancer Organization and the University of Twente and published in the BMJ — retrospectively looked at the cases of 174,000 Dutch women. The population was broken into two large cohorts: women diagnosed with breast cancer between 1999 and 2005 (80,228 women, median age 59) and women diagnosed 2006-2012 (93,569 women, median age 60). According to study authors, the two cohorts were selected due to significant changes in the screening guidelines in 2005.

Elaine Schattner, M.D., in a piece on the study for Forbes, said there are two key takeaways from the results:

  • Overall survival was significantly shorter for women whose breast cancer had spread to the lymph nodes; and
  • Larger, invasive tumors had a significantly greater impact on long-term survival than smaller invasive cancers.

Schattner also noted that data from the period of 2006-2012 indicated more early-stage diagnoses and low-grade tumors, increases in lumpectomy and increased use of medicines including hormonal treatments.

Study authors note that the Netherlands instituted a national biennial mammography screening program in 1989; the program was initially targeted for all women age 50-69 and was expanded to included women age 71-75 in 1998.

The Dutch study findings go against the modern view, held in some circles, that early detection has little value. According to Schattner, this view is largely based on a 2012 study in the New England Journal of Medicine that attributed improvements in breast cancer survival rates to better treatment options as opposed to mammography screening.

For more information:

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...